@article{QuinklerBeuschleinHahneretal.2013,
  author    = {Quinkler, Marcus and Beuschlein, Felix and Hahner, Stefanie and Meyer, Gesine and Sch{\"o}fl, Christof and Stalla, G{\"u}nter K.},
  title     = {Adrenal Cortical Insufficiency-a Life Threatening Illness With Multiple Etiologies},
  series = {Deutsches {\"A}rzteblatt International},
  volume    = {110},
  journal   = {Deutsches {\"A}rzteblatt International},
  doi       = {10.3238/arztebl.2013.0882},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-131662},
  pages     = {51-52},
  year      = {2013},
  abstract  = {Background: The clinical signs of adrenal cortical insufficiency (incidence, ca. 25 per million per year; prevalence, ca. 400 per million) are nonspecific, and misdiagnoses are therefore common. Glucocorticoid substitution therapy has been in use for 50 years but is not a wholly adequate treatment. Our understanding of this disease remains incomplete in many ways. Methods: We selectively searched the Medline database for publications on adrenal cortical insufficiency, with particular attention to studies from the year 2000 onward (search terms: "adrenal insufficiency" or "Addison's disease" or "hypopituitarism"). Results: Hydrocortisone substitution therapy is often given in doses of 10-25 mg/day, timed according to the circadian rhythm. Gastrointestinal and other, febrile infections account for 30-50\% of life-threatening adrenocortical crises. Such crises affect 8 of 100 persons with adrenal cortical insufficiency per year and must be treated by the immediate administration of glucocorticoids and fluids. When persons with adrenal cortical insufficiency are acutely ill or are otherwise under unusual stress, they may need additional amounts of hydrocortisone, often in the range of 5-10 mg but occasionally as high as 200 mg. The sustained administration of excessive amounts of steroid can shorten patients' lives by several years. Inappropriate substitution therapy can cause other major medical conditions, such as metabolic syndrome and osteoporosis. Conclusion: Important measures for the prevention of adrenocortical crises include improved care by treating physicians, education of patients and their families, the provision of emergency identifying documents, and the prescription of glucocorticoid emergency kits.},
  language  = {en}
}
@phdthesis{Meyer2021,
  author    = {Meyer, Stefanie},
  title     = {Der „Discursus medicus et politicus" von Tobias Geiger (1656). Edition und Kommentar},
  doi       = {10.25972/OPUS-23285},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-232856},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2021},
  abstract  = {Der „Discursus medicus et politicus" von Tobias Geiger ist eine Handschrift aus dem Jahr 1656. Als eine Art Lebensbericht stellt das Werk ein Pl{\"a}doyer f{\"u}r die Chirurgie als wichtigen Bestandteil der Medizin dar. Tobias Geiger skizziert nicht nur einen „rechten medicus" in „tempore pacis, belli et pestis", sondern er besch{\"a}ftigt sich zudem mit gesundheitspolitischen Themen, wie die Vereinigung von Chirurgie und Medizin in der Ausbildung, die Abschaffung sowohl von der Landfahrerei als auch von unqualifizierten Heilpersonen, die Pr{\"u}fung des Heilpersonals sowie die Verbesserung der Spit{\"a}ler. In der vorliegenden Dissertation wurde das Schriftst{\"u}ck zun{\"a}chst editiert, die lateinischen Passagen {\"u}bersetzt und kommentiert. Im Anschluss wurden die Inhalte f{\"u}r ein besseres Verst{\"a}ndnis weiter aufgegliedert und in den historischen Kontext gestellt.},
  subject      = {Geiger, Tobias},
  language  = {de}
}
@article{KosterGurumurthyKumaretal.2022,
  author    = {Koster, Stefanie and Gurumurthy, Rajendra Kumar and Kumar, Naveen and Prakash, Pon Ganish and Dhanraj, Jayabhuvaneshwari and Bayer, Sofia and Berger, Hilmar and Kurian, Shilpa Mary and Drabkina, Marina and Mollenkopf, Hans-Joachim and Goosmann, Christian and Brinkmann, Volker and Nagel, Zachary and Mangler, Mandy and Meyer, Thomas F. and Chumduri, Cindrilla},
  title     = {Modelling Chlamydia and HPV co-infection in patient-derived ectocervix organoids reveals distinct cellular reprogramming},
  series = {Nature Communications},
  volume    = {13},
  journal   = {Nature Communications},
  number    = {1},
  doi       = {10.1038/s41467-022-28569-1},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-301349},
  year      = {2022},
  abstract  = {Coinfections with pathogenic microbes continually confront cervical mucosa, yet their implications in pathogenesis remain unclear. Lack of in-vitro models recapitulating cervical epithelium has been a bottleneck to study coinfections. Using patient-derived ectocervical organoids, we systematically modeled individual and coinfection dynamics of Human papillomavirus (HPV)16 E6E7 and Chlamydia, associated with carcinogenesis. The ectocervical stem cells were genetically manipulated to introduce E6E7 oncogenes to mimic HPV16 integration. Organoids from these stem cells develop the characteristics of precancerous lesions while retaining the self-renewal capacity and organize into mature stratified epithelium similar to healthy organoids. HPV16 E6E7 interferes with Chlamydia development and induces persistence. Unique transcriptional and post-translational responses induced by Chlamydia and HPV lead to distinct reprogramming of host cell processes. Strikingly, Chlamydia impedes HPV-induced mechanisms that maintain cellular and genome integrity, including mismatch repair in the stem cells. Together, our study employing organoids demonstrates the hazard of multiple infections and the unique cellular microenvironment they create, potentially contributing to neoplastic progression.},
  language  = {en}
}